C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
12/2006
12/07/2006	US20060276657 Process for the preparation of anticancer drugs
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	CA2611129A1 Derivatives of a 1-phenyltriazole as antiparasitic agents
12/06/2006	EP1728784A1 Fluorene derivative
12/06/2006	EP1727820A2 Amine derivatives
12/06/2006	EP1727807A1 Antiozonant based functionalized benzotriazole uv absorbers and the process thereof
12/06/2006	EP1727804A1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
12/06/2006	EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
12/06/2006	CN1874777A 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/05/2006	US7144911 Anti-inflammatory medicaments
12/05/2006	US7144908 Prophylaxis, therapy of respiratory system disorders
11/2006
11/30/2006	WO2006017409A3 1,3-disubstituted heteroaryl nmda/nr2b antagonists
11/30/2006	US20060270725 N[S(4-aryl-triazol-3-yl)alpha-mercaptoacetyl]-p-amino benzoic acids as HIV reverse transcriptase inhibitors
11/30/2006	US20060270724 3-[p-(substituted benzyloxy)- or p-(substituted -5-thiazolylmethoxy)phenyl]propionic acid derivatives in which the propionic acid is 3-substituted with a carbamoyl-, imidazolyl-, triazolyl-, tetrazolyl-, or oxazolyl group; activating G-protein coupled receptor 40; treatment of type II diabetes
11/30/2006	US20060270719 2-[(Cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-2-yl-benzyl)-amino]-N-hydroxy-acetamide; selective inhibitors of matrix-degrading metalloproteinases, especially MT1-MMP, MMP-2 and MMP-9; Osteoporosis; Antitumor, antiproliferative agents
11/29/2006	EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006	EP1725549A1 Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
11/29/2006	EP1725231A1 Triazole, oxadiazole and thiadiazole derivatives as ppar modulators for the treatment of diabetes
11/29/2006	EP1076053B1 3-arylphenyl sulfide derivatives and insecticides and miticides
11/29/2006	CN1871208A Aralkyl amines as cannabinoid receptor modulators
11/29/2006	CN1287227C Electric photographic organic photoreceptor with charge transfer matter
11/29/2006	CN1286818C Method for preparing triazolinthionone derivative
11/28/2006	US7141688 Quenching efficiency; improving colorfastness; photooxidation and heat resistance; electrophoretic fluid displays; containing metal complexed ortho-hydroxyimino phenol functionality
11/28/2006	US7141685 Colorfastness; photostability; solubility; coloring polymers
11/28/2006	US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/23/2006	WO2006124687A1 Opioid receptor subtype-selective agents
11/23/2006	WO2006108155A3 Process for the preparation of anastrozole
11/23/2006	WO2006081034A3 Anti-inflammatory medicaments
11/23/2006	WO2005112941A3 Substituted cyclic urea derivatives
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264484 Fc receptor modulating compounds and compositions
11/23/2006	US20060264483 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/23/2006	US20060264475 Compounds, compositions and methods for inhibiting or treating hiv-1
11/22/2006	EP1723124A1 Propenoyl hydrazides
11/22/2006	EP1723123A1 Ion channel modulators
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1722863A1 Microcapsules with uv filter activity and process for producing them
11/22/2006	EP1722788A2 Ion channel modulators
11/22/2006	EP1534265B1 Combination of an aromatase inhibitor with a bisphosphonate
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	CN1867569A 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/22/2006	CN1285590C Itraconazole hydrochloride oral solid composition and preparation method
11/21/2006	US7138539 Colorant compounds containing copolymerizable vinyl groups
11/21/2006	US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006	US7138414 Antidiabetic agents
11/21/2006	CA2272285C Amide derivatives and medicinal compositions thereof
11/16/2006	WO2006120133A2 Process for coloring keratin fibers comprising metal complexes
11/16/2006	WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006	US20060258718 Carbamic acid (R)-(+)-1-(2-chloro-phenyl)-2-tetrazol-2-yl-ethyl ester ; anticonvulsants; anxiety, depression, convulsion, epilepsy, migraine, bipolar disorder, drug abuse, smoking, ADHD, obesity, sleep disorder, neuropathic pain, stroke, cognitive impairment, neurodegeneration, stroke and muscle spasm
11/16/2006	US20060258695 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
11/16/2006	US20060258536 Sulfonylamino(thio)carbonyl compounds
11/15/2006	EP1720860A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
11/15/2006	EP1720843A2 Process for the preparation of substituted triazole compounds
11/15/2006	EP1720546A1 Novel, sustained-action beta-2-agonists and their use as medicaments
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1861582A Cyclopropyl substituded triazol kind anti fungus compound and preparation process and use thereof
11/14/2006	US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006	US7135475 Antidiabetic agents
11/14/2006	US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers
11/14/2006	CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006	WO2006119304A1 Radiation-absorbing polymeric materials and ophthalmic devices comprising same
11/09/2006	WO2006117657A1 Triazolone derivatives as anti-inflammatory agents
11/09/2006	WO2006028963A3 Substituted heterocyclic compounds and uses thereof
11/08/2006	EP1718622A2 Electroluminescent device
11/08/2006	CN1860186A Azo compound, aqueous dye solutions containing the same, inks and use thereof
11/08/2006	CN1283630C 3-substituted piperazine triadimenol antifungal compounds and their salts
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132437 for example, methyl 4'-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl][1,1'-biphenyl]-2-carboxylate; for treatment of congestive heart failure
11/07/2006	US7132001 Oxidative dye couplers; light, wash and rub fastness; storage stability; intense shades
11/07/2006	CA2284775C Preparation of low-dust stabilisers
11/02/2006	WO2006116629A2 The preparation of molecular imaging probes using click chemistry
11/02/2006	WO2006114575A1 Novel development accelerator-releasing couplers
11/02/2006	WO2006114377A1 Electroluminescent device
11/02/2006	WO2006114262A1 Acetylene derivatives
11/02/2006	WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	WO2006114221A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
11/02/2006	WO2006087077A3 Hsp90-inhibiting triazole derivatives
11/02/2006	WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	EP1717228A1 Sulfonylamino(thio)carbonylderivatives as herbicides or plant growth regulators
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716129A1 Piperazine derivatives which exhibit acivity as serotonin and noradrenaline re-upatke inhibitors
11/02/2006	EP1716127A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/02/2006	EP1716100A2 Therapeutic amide derivatives
11/02/2006	EP1399117B1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
11/02/2006	CA2606268A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
11/02/2006	CA2606094A1 The preparation of molecular imaging probes using click chemistry
11/02/2006	CA2605265A1 Acetylene derivatives
11/02/2006	CA2605262A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/01/2006	CN1856480A P-38 kinase inhibitors
11/01/2006	CN1856479A Gamma-secretase inhibitors
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/31/2006	US7129361 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
10/31/2006	US7129198 Use of benzotriazole UV absorbers
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/25/2006	CN1850809A Benzotriazole compound containing sulfur, and its preparing method

1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 178